Home Search Abstracts View Session E-mail Abstract Author


Session 34 Symposium
Emerging Strategies for the Treatment of HIV
Session Day and Time: Tuesday, 7:10 - 9:10 pm
Room: West Hall B


107
The Potential for Exploiting Host Restriction Factors for Therapy
Reuben Harris
Univ of Minnesota, Minneapolis, US

Background:  Over the past few years several host proteins with potent anti-viral activity have been detailed. In particular, the APOBEC3F and APOBEC3G proteins can strongly block the replication of Vif-defective HIV-1. Much of this inhibitory activity is manifested through the deamination of viral cDNA cytosines to uracils during reverse transcription. However, this rarely occurs in vivo because the viral accessory protein Vif effectively neutralizes these APOBEC3 proteins. Vif is therefore required for virus replication.

Conclusions:  Strategies to modulate this delicate balance and thereby protect these host APOBEC3 proteins from Vif will be discussed.